BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11882027)

  • 1. B7-1 and B7-2 co-stimulatory molecules are required for mercury-induced autoimmunity.
    Bagenstose LM; Class R; Salgame P; Monestier M
    Clin Exp Immunol; 2002 Jan; 127(1):12-9. PubMed ID: 11882027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of deviating the Th2-response in murine mercury-induced autoimmunity towards a Th1-response.
    Häggqvist B; Hultman P
    Clin Exp Immunol; 2003 Nov; 134(2):202-9. PubMed ID: 14616778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
    Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
    Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Th2-response in mercuric chloride-induced autoimmunity requires continuing costimulation via CD28.
    Macphee IA; Turner DR; Yagita H; Oliveira DB
    Clin Exp Immunol; 2002 Sep; 129(3):405-10. PubMed ID: 12197880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mercury-induced autoimmunity in the absence of IL-4.
    Bagenstose LM; Salgame P; Monestier M
    Clin Exp Immunol; 1998 Oct; 114(1):9-12. PubMed ID: 9764596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICOS-B7 homologous protein interactions are necessary for mercury-induced autoimmunity.
    Zheng Y; Jost M; Gaughan JP; Class R; Coyle AJ; Monestier M
    J Immunol; 2005 Mar; 174(5):3117-21. PubMed ID: 15728528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.
    Ryan M; McCarthy L; Rappuoli R; Mahon BP; Mills KH
    Int Immunol; 1998 May; 10(5):651-62. PubMed ID: 9645613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD80(B7.1) and CD86(B7.2) do not have distinct roles in setting the Th1/Th2 balance in autoimmunity in rats.
    MacPhee IA; Turner DR; Yagita H; Oliveira DB
    Scand J Immunol; 2001 Nov; 54(5):486-94. PubMed ID: 11696200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of costimulatory molecules B7-1 and B7-2 on microglial cells induced by Th1 and Th2 cells in organotypic brain tissue.
    Wolf SA; Gimsa U; Bechmann I; Nitsch R
    Glia; 2001 Dec; 36(3):414-20. PubMed ID: 11746777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation.
    Mark DA; Donovan CE; De Sanctis GT; Krinzman SJ; Kobzik L; Linsley PS; Sayegh MH; Lederer J; Perkins DL; Finn PW
    Int Immunol; 1998 Nov; 10(11):1647-55. PubMed ID: 9846693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity.
    Nuriya S; Yagita H; Okumura K; Azuma M
    Int Immunol; 1996 Jun; 8(6):917-26. PubMed ID: 8671681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.
    Kuchroo VK; Das MP; Brown JA; Ranger AM; Zamvil SS; Sobel RA; Weiner HL; Nabavi N; Glimcher LH
    Cell; 1995 Mar; 80(5):707-18. PubMed ID: 7534215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genotype determines the B cell response in mercury-treated mice.
    Johansson U; Hansson-Georgiadis H; Hultman P
    Int Arch Allergy Immunol; 1998 Aug; 116(4):295-305. PubMed ID: 9693280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
    Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
    Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of B7-2, not B7-1, inhibits purified protein derivative-primed T-lymphocyte responses but fails to influence the proportion of Th1 versus Th2 subsets.
    Shortt J; Hart DN; Watson JD; Baird MA
    Scand J Immunol; 1998 Apr; 47(4):355-62. PubMed ID: 9600317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive and autoimmune effects of thimerosal in mice.
    Havarinasab S; Häggqvist B; Björn E; Pollard KM; Hultman P
    Toxicol Appl Pharmacol; 2005 Apr; 204(2):109-21. PubMed ID: 15808517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell co-stimulatory molecules are upregulated on intestinal macrophages from inflammatory bowel disease mucosa.
    Rogler G; Hausmann M; Spöttl T; Vogl D; Aschenbrenner E; Andus T; Falk W; Schölmerich J; Gross V
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1105-11. PubMed ID: 10524639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.